GLYBEK® is an oral antidiabetic drug from the class of alpha - glucosidase inhibitors; indicated in non-insulin-dependent diabetes mellitus (type 2) in adults, as an adjunct to the diet.
| DCI | ACARBOSE |
|---|---|
| Dosage | 50 mg |
| Trade name | GLYBEK® |
| Name of the originator | Glucobay |
| Presentation | 30 tablets |
| Specialty | Métabolisme – ADO |
